A medical device proof-of-concept (POC) study is a focused, early investigation designed to answer one specific feasibility question. It is not a guarantee of market approval. It is not a substitute for formal design verification and validation. It is a controlled way to find out, early and cheaply, whether your core assumption holds up.
This article covers what POC studies evaluate, how to plan one that produces a real decision, why so many fail, and how to carry useful evidence forward into a manufacturable orthopedic device.
Key Takeaways
- A POC answers a clearly defined feasibility question with measurable success criteria, not a vague hope that "it works."
- POC studies are distinct from prototypes, MVPs, design verification, validation, and clinical studies.
- Scope should match the device's intended use, technical risk, and regulatory pathway.
- Documentation and early manufacturing input preserve evidence for later development stages.
- Failed POCs still have value when they identify a specific design, safety, or manufacturing constraint.
What a Medical Device POC Study Is—and Is Not
A POC study demonstrates whether a core concept or critical feature appears technically feasible under defined conditions. It is narrow by design—and nothing more.
What a POC Can Evaluate
A well-scoped POC typically examines one of the following:
- Basic mechanism of action (for example, whether a locking feature actually locks)
- Component interaction or dimensional fit
- Material behavior under load or cyclic stress
- Sensing, signal, or communication function
- Workflow or surgical-technique compatibility
POC vs. Prototype, MVP, and Verification
These terms get used interchangeably, and that's a problem.
- A prototype is a more developed physical model used to refine function and usability—often built after a POC confirms the basic concept works.
- An MVP is the minimum feature set built for meaningful user or market testing, and it assumes core feasibility is already settled.
- Design verification/validation produces formal evidence against defined design inputs and intended use, under much stricter documentation requirements than an exploratory POC.
FDA guidance on non-clinical bench performance testing draws the same distinction: the test article is separate from the study's objective, methods, and results—not interchangeable labels (FDA, 2019). Keeping those lines clear also clarifies what a POC cannot claim.
What a POC Does Not Establish
A successful POC does not prove:
- Complete safety or biocompatibility
- Clinical effectiveness
- Regulatory clearance
- Production readiness
- Long-term reliability
Before full engineering on a new spinal implant interface, a team might run a bench POC that asks only whether the interlocking geometry resists a defined shear load under simulated anatomical conditions. The question should be narrow enough to force a decision:
- Proceed
- Redesign
- Test an alternative material
- Stop
Why POC Studies Matter in Medical Device Development
Early feasibility evidence reduces the risk of investing heavily in a concept before testing its most important assumptions. That's the whole point.
POC findings feed directly into:
- Design inputs and preliminary risk analysis
- Material selection and test method design
- User research and future verification planning
The same findings serve different stakeholders:
- Founders justify continued investment
- Investors gauge technical risk
- Engineers decide where to focus redesign
- Quality and manufacturing teams flag feasibility issues before tooling locks in
The cost and rigor of the study should scale with the device's novelty, intended use, risk classification, and the consequences of failure. A novel spinal interface warrants more rigorous testing than an incremental change to an established fixation plate.
A 2023 peer-reviewed bench study on a polymeric spinal nucleus-replacement implant illustrates this well. Researchers compared two designs — one with an added central partition for strength, one without — through static and fatigue testing.
At 10 million cycles, the reinforced design showed threefold more extensive wear than the simpler one. The authors selected the simpler design for further biomechanical testing, citing more homogeneous behavior, while explicitly noting the comparison involved only two designs and no in-vivo data. That's a real example of feasibility evidence directly shaping a development decision, without overstating what the data proved.
How to Plan and Run a Medical Device POC Study
Start With the Question, Not the Build
Convert the clinical or user need into one or more testable feasibility questions. Identify the intended user, use environment, relevant anatomy or workflow, and the single assumption that could prevent the concept from working.
Keep technical, clinical, usability, regulatory, and manufacturing questions separate. Trying to prove everything in one study is how studies become unreadable.
Define Objectives and Acceptance Criteria First
Before building or testing anything, lock down:
- The study objective: what you're trying to learn
- The hypothesis: what you expect and why
- Endpoints: fit, motion, force, dimensional stability, signal behavior, or usability observation
- Acceptance criteria: realistic for an early study, but meaningful enough to support a go/no-go decision
Select a Representative Test Article and Method
Document the prototype or mock-up before testing:
- Materials, dimensions, and tolerances
- Build method
- Known limitations
Match the method to the question: bench testing, simulated-use evaluation, computational analysis, or formative usability work, depending on what you're actually trying to learn.
Standards bodies provide useful scope references here, though none of them function as a universal POC protocol:
| Standard | Relevant Use | Key Limitation |
|---|---|---|
| ASTM F2077-24 | Spinal fusion device lab comparisons | Excludes bone-implant interface |
| ASTM F382-24 | Metallic bone plate bending/fatigue | Single-cycle, not full construct |
| ASTM F3437-23 | Small-bone fracture plate testing | Not in-vivo performance evidence |
| ASTM F1800-19e1 | Tibial tray cyclic fatigue | Lab comparison only |
Build In Risk and Regulatory Awareness
Identify foreseeable hazards and failure modes before testing begins. Document how the study will control or record them.
FDA has noted in recent QMSR town-hall discussions that design-and-development requirements aren't intended to apply to feasibility or POC work. Manufacturers still need to document clearly where exploratory research ends and controlled development begins (FDA QMSR town hall transcript).
Execute Consistently and Close With a Decision
Record sample rationale, test conditions, operators, equipment, deviations, and failures. If usability or workflow is part of the feasibility question, include qualitative input from clinicians or technicians who'd actually use the device.
End with a report that states, plainly, whether each objective was met, partially met, or not met. Inconclusive results should trigger a refined question or method, not an unsupported claim that the concept works.
Turning POC Evidence Into a Manufacturable Device
A concept that works once on a bench isn't necessarily a concept that can be machined, inspected, assembled, sterilized, and produced consistently at scale. That gap trips up more orthopedic programs than it should.
Design-for-manufacturability checks worth running early include:
- Material availability at production volumes
- Geometry and tolerance feasibility
- Surface finish requirements
- Tool access and fixturing strategy
- Repeatability across batches
- Inspection strategy for critical dimensions
POC and prototype documentation should preserve the thread connecting design requirements, CAD or drawing revisions, test articles, measured results, and proposed changes. Lose that thread, and you lose the ability to explain why a design looks the way it does six months later.
When dimensional accuracy and mechanical performance sit at the center of the feasibility question, producing representative prototypes or first articles (not just quick mock-ups) matters.
This is where a manufacturing partner with orthopedic-specific experience earns its keep. MoManTech, an ISO 13485:2016-certified contract manufacturer based in Sheridan, Montana, works exclusively with spinal, trauma, large joint, and foot/ankle OEMs.
Capabilities that support the POC-to-production handoff include:
- Precision CNC machining, wire EDM, and additive manufacturing
- Prototype quantities of 1–10 units through production runs of 100+
- Comprehensive inspection on every batch, including CMM and laser measurement
For teams turning POC learning into machined first articles, that design-for-manufacturability input can catch tolerance or fixturing problems before they become expensive redesigns.
Manufacturing support complements clinical, preclinical, biocompatibility, and regulatory expertise. It doesn't replace any of it.
Common Reasons Medical Device POC Studies Fail
Most POC failures aren't really about the science. They're about scope, setup, and documentation.
- Unclear or overly broad objectives — testing every feature at once yields ambiguous results. Keep one narrow, measurable objective per study.
- Nonrepresentative test conditions — unsuitable materials, simplified anatomy, or weak simulated-use setups fail to exercise the critical function.
- Weak documentation — inconsistent methods, missing failure records, and no traceability leave results hard to defend.
- Late attention to users, risk, and regulatory expectations — skipping clinicians or applicable requirements can make positive results useless downstream.
- Unplanned manufacturing limits — prototype variability, missing equipment, or budget caps that weren't scoped upfront derail execution.
A 2021 peer-reviewed cadaveric study of a load-sharing knee implant shows how disciplined scoping looks in practice. The researchers labeled the work a proof-of-concept study of implant attachment and contact pressure, but used only two specimens and noted that a larger study with statistical analysis was still needed.
That restraint is the point: they stated the study's limits instead of overstating its reach.
A failed POC still becomes useful evidence when it does four things:
- Identifies the failed assumption
- Documents the test conditions
- Separates prototype defects from concept defects
- Defines what to try next
From POC Results to the Next Development Gate
Every POC should end at one of three places:
- Proceed to a more representative prototype or formal verification plan
- Revise and repeat the POC with a refined question or method
- Stop or redirect the concept entirely
What gets carried forward matters as much as the decision itself:
- Objective results and test conditions
- Deviations and updated risk assessments
- Design changes and unresolved questions
- Manufacturing observations from anyone who built the test articles
From there, teams move into formal design controls, verification and validation planning, clinical or preclinical work where applicable, regulatory submissions, and production transfer.
Before freezing major design decisions, bring these groups into the same review:
- Product development
- Clinical or user representatives
- Quality and regulatory specialists
- Manufacturing personnel
If your orthopedic program has reached the point of needing machined first articles or a scalable manufacturing plan from POC learnings, MoManTech works with spinal, trauma, large joint, and foot/ankle OEMs on manufacturability review, inspection planning, and production-readiness needs — from single-digit prototype quantities through full production runs.
Frequently Asked Questions
What is a proof-of-concept device?
A proof-of-concept device is an early test article used to demonstrate whether a core function or concept is technically feasible. It is not necessarily production-ready, safety-validated, or regulatory-approved.
What is an example of POC?
One common example is testing whether a new spinal implant interface or trauma fixation component can meet a basic performance requirement, such as resisting a specified load, before full engineering development begins.
What are the key characteristics of a testable proof-of-concept?
A testable concept defines the intended use, user need, essential function, known constraints, risks, underlying assumptions, and measurable feasibility criteria.
What is the difference between ISO 13485 and EU MDR?
ISO 13485:2016 is a quality-management-system standard for organizations involved in medical device design and production. EU MDR (Regulation 2017/745) is European Union law governing device safety, conformity assessment, and market access. It is a regulation, not a QMS standard.
Which countries does EU MDR apply to?
EU MDR primarily applies to devices placed on the market in European Union member states, with related obligations affecting certain EEA-associated markets. Confirm current applicability with qualified regulatory counsel.
